← Back to Clinical Trials
Recruiting NCT06821581

Economic-demographic Assessment of the Aseptic Mobilization of Knee Prostheses Through the RIPO Registry and Radiographic Analysis of the Case Series From the II Clinic of IOR

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

Condition Aseptic Loosening
Sponsor Istituto Ortopedico Rizzoli
Study Type OBSERVATIONAL
Phase N/A
Enrollment 31
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2026-02
Completion 2026-12-31

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The increase in life expectancy is leading to an increase in the average age of patients undergoing total knee arthroplasty (TKA), and, consequently, an increase in the number of revisions. The main cause of TKA failure is aseptic mobilization, which is described as the loss of integration between the prosthetic component and the bone in the absence of infection. This represents a significant impact on professional and economic resources for the Italian healthcare system. Aseptic mobilization can be caused by inadequate initial fixation of the implant and/or mechanical or biological loss of fixation over time, factors that often occur simultaneously. A careful, methodical evaluation of post-operative radiographs of TKAs remains an important diagnostic tool. The analysis of the causes of aseptic mobilization of TKAs and the associated economic impact in the Emilia Romagna region is useful for providing an estimate of the problem and identifying potential areas for improvement.

Eligibility Criteria

Inclusion Criteria: * Patients undergoing knee prosthesis revision for aseptic mobilization * Follow-up ≥ 2 years * Willingness to participate in the study * Both sexes * Patients ≥ 18 years old Exclusion Criteria: * Patient refusal to participate in the study and sign the informed consent * Simultaneous participation in other studies

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology
}